9/17/2019  10:15:01 PM Chg. - Volume Bid6/28/2019 Ask7/4/2019 Market Capitalization Dividend Y. P/E Ratio
45.200CHF - -
Turnover: -
45.200Bid Size: 470 52.000Ask Size: 100 10.63 bill.CHF - -

Business description

Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
 

Management board & Supervisory board

CEO
Peder Holk Nielsen
Management board
Prisca Havranek-Kosicek, Anders Lund, Andrew Fordyce, Thomas Videbæk, Tina Sejersgård Fanø
Supervisory board
Jørgen Buhl Rasmussen, Agnete Raaschou-Nielsen, Andreas Hentze Knudsen, Kasim Kutay, Kim Stratton, Lars Bo Køppler, Lars Green, Lena Bech Holskov, Mathias Uhlén
 

Company data

Name: Novozymes A.S
Address: Krogshoejvej 36,DK-2880 Bagsvaerd
Phone: +45-44-460000
Fax: -
E-mail: -
Internet: www.novozymes.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 50.00%
IPO date: 11/20/2000

Investor relations

Name: Tobias Cornelius Björklund
IR phone: +45-3077-8682
IR Fax: -
IR e-mail: NovozymesIR@novozymes.com

Company calendar

CW 43 | 10/23/2019 Interim Report 3rd Quarter/9 Months
CW 4 | 1/23/2020 4th Quarter/Annual Report
CW 9 | 2/26/2020 General Shareholder Meeting
 

Main Shareholders

Novo A/S
 
50.00%
Freefloat
 
50.00%